Dimitrios Daoussis
Dimitrios Daoussis
University of Patras Medical School, Deparment of Rheumatology
Verified email at upatras.gr
Title
Cited by
Cited by
Year
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
D Daoussis, SNC Liossis, AC Tsamandas, C Kalogeropoulou, A Kazantzi, ...
Rheumatology 49 (2), 271-280, 2010
3502010
Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitis
D Daoussis, SNC Liossis, EE Solomou, A Tsanaktsi, K Bounia, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2010
2302010
Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis
D Daoussis, SC Liossis, AC Tsamandas, C Kalogeropoulou, ...
Clinical and Experimental Rheumatology-Incl Supplements 30 (2), S17, 2012
1772012
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
D Daoussis, K Melissaropoulos, G Sakellaropoulos, I Antonopoulos, ...
Seminars in arthritis and rheumatism 46 (5), 625-631, 2017
1082017
The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?
D Daoussis, AP Andonopoulos
Seminars in arthritis and rheumatism 41 (2), 170-177, 2011
1072011
Experience with infliximab (anti-TNFα monoclonal antibody) as monotherapy for giant cell arteritis
AP Andonopoulos, N Meimaris, D Daoussis, A Bounas, G Giannopoulos
Annals of the Rheumatic Diseases 62 (11), 1116-1116, 2003
882003
Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis
D Daoussis, AP Andonopoulos, SNC Liossis
Seminars in arthritis and rheumatism 39 (5), 369-383, 2010
782010
Targeting CD40L: a promising therapeutic approach
D Daoussis, AP Andonopoulos, SNC Liossis
Clinical and diagnostic laboratory immunology 11 (4), 635-641, 2004
782004
Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature
D Daoussis, I Antonopoulos, SNC Liossis, G Yiannopoulos, ...
Seminars in arthritis and rheumatism 41 (6), 822-829, 2012
742012
Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis
D Daoussis, VF Panoulas, I Antonopoulos, H John, TE Toms, P Wong, ...
Annals of the rheumatic diseases 69 (3), 517-521, 2010
602010
Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature
D Daoussis, SNC Liossis, AC Tsamandas, C Kalogeropoulou, A Kazantzi, ...
Seminars in arthritis and rheumatism 40 (2), 127-136, 2010
572010
B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence
D Daoussis, SNC Liossis, G Yiannopoulos, AP Andonopoulos
International journal of rheumatology 2011, 2011
432011
Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis
D Daoussis, I Antonopoulos, AP Andonopoulos, SNC Liossis
Rheumatology 46 (2), 227-231, 2007
392007
Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
AP Andonopoulos, N Meimaris, D Daoussis, A Bounas, G Yiannopoulos
Clinical and experimental rheumatology 21 (4 Suppl 30), S57-8, 2003
372003
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis
D Daoussis, V Panoulas, T Toms, H John, I Antonopoulos, P Nightingale, ...
Arthritis research & therapy 11 (4), R116, 2009
362009
The infectious basis of ACPA-positive rheumatoid arthritis
LI Sakkas, D Daoussis, SN Liossis, DP Bogdanos
Frontiers in microbiology 8, 1853, 2017
352017
Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study
D Vassilopoulos, EM Delicha, L Settas, A Andrianakos, S Aslanidis, ...
Clin Exp Rheumatol 34 (5), 893-900, 2016
312016
Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus
S Mavrogeni, L Koutsogeorgopoulou, G Markousis-Mavrogenis, ...
Lupus 27 (4), 564-571, 2018
302018
B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin
D Daoussis, AC Tsamandas, SNC Liossis, I Antonopoulos, E Karatza, ...
Arthritis research & therapy 14 (3), R145, 2012
302012
Biologics in SAPHO syndrome: a systematic review
D Daoussis, G Konstantopoulou, P Kraniotis, L Sakkas, SN Liossis
Seminars in arthritis and rheumatism 48 (4), 618-625, 2019
252019
The system can't perform the operation now. Try again later.
Articles 1–20